SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia

Constanze Schneider; Thomas Oellerich; Hanna-Mari Baldauf; Sarah-Marie Schwarz; Dominique Thomas; Robert Flick; Hanibal Bohnenberger; Lars Kaderali; Lena Stegmann; Anjali Cremer; Margarethe Martin; Julian Lohmeyer; Martin Michaelis; Veit Hornung; Christoph Schliemann; Wolfgang E. Berdel; Wolfgang Hartmann; Eva Wardelmann; Federico Comoglio; Martin-Leo Hansmann; Alexander F. Yakunin; Gerd Geisslinger; Philipp Stroebel; Nerea Ferreiros; Hubert Serve; Oliver T. Keppler; Jindrich, Jr. Cinatl

doi:10.1038/nm.4255

SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia

Constanze Schneider, Thomas Oellerich, Hanna-Mari Baldauf, Sarah-Marie Schwarz, Dominique Thomas, Robert Flick, Hanibal Bohnenberger, Lars Kaderali, Lena Stegmann, Anjali Cremer, Margarethe Martin, Julian Lohmeyer, Martin Michaelis, Veit Hornung, Christoph Schliemann, Wolfgang E. Berdel, Wolfgang Hartmann, Eva Wardelmann, Federico Comoglio, Martin-Leo HansmannAlexander F. Yakunin, Gerd Geisslinger, Philipp Stroebel, Nerea Ferreiros, Hubert Serve, Oliver T. Keppler, Jindrich, Jr. Cinatl

University of Toronto, Canada

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	250-255
Journal	Nature Medicine
Volume	23
Issue number	2
Early online date	19 Dec 2016
DOIs	https://doi.org/10.1038/nm.4255
Publication status	Published - Feb 2017
Externally published	Yes

Access to Document

10.1038/nm.4255

Cite this

Schneider, C., Oellerich, T., Baldauf, H.-M., Schwarz, S.-M., Thomas, D., Flick, R., Bohnenberger, H., Kaderali, L., Stegmann, L., Cremer, A., Martin, M., Lohmeyer, J., Michaelis, M., Hornung, V., Schliemann, C., Berdel, W. E., Hartmann, W., Wardelmann, E., Comoglio, F., ... Cinatl, J. J. (2017). SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia. Nature Medicine, 23(2), 250-255. https://doi.org/10.1038/nm.4255

@article{d8dc7fc61c184385bb6b256e91eafe83,

title = "SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia",

author = "Constanze Schneider and Thomas Oellerich and Hanna-Mari Baldauf and Sarah-Marie Schwarz and Dominique Thomas and Robert Flick and Hanibal Bohnenberger and Lars Kaderali and Lena Stegmann and Anjali Cremer and Margarethe Martin and Julian Lohmeyer and Martin Michaelis and Veit Hornung and Christoph Schliemann and Berdel, {Wolfgang E.} and Wolfgang Hartmann and Eva Wardelmann and Federico Comoglio and Martin-Leo Hansmann and Yakunin, {Alexander F.} and Gerd Geisslinger and Philipp Stroebel and Nerea Ferreiros and Hubert Serve and Keppler, {Oliver T.} and Cinatl, {Jindrich, Jr.}",

year = "2017",

month = feb,

doi = "10.1038/nm.4255",

language = "English",

volume = "23",

pages = "250--255",

journal = "Nature Medicine",

issn = "1078-8956",

publisher = "Nature Research",

number = "2",

}

Schneider, C, Oellerich, T, Baldauf, H-M, Schwarz, S-M, Thomas, D, Flick, R, Bohnenberger, H, Kaderali, L, Stegmann, L, Cremer, A, Martin, M, Lohmeyer, J, Michaelis, M, Hornung, V, Schliemann, C, Berdel, WE, Hartmann, W, Wardelmann, E, Comoglio, F, Hansmann, M-L, Yakunin, AF, Geisslinger, G, Stroebel, P, Ferreiros, N, Serve, H, Keppler, OT & Cinatl, JJ 2017, 'SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia', Nature Medicine, vol. 23, no. 2, pp. 250-255. https://doi.org/10.1038/nm.4255

TY - JOUR

T1 - SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia

AU - Schneider, Constanze

AU - Oellerich, Thomas

AU - Baldauf, Hanna-Mari

AU - Schwarz, Sarah-Marie

AU - Thomas, Dominique

AU - Flick, Robert

AU - Bohnenberger, Hanibal

AU - Kaderali, Lars

AU - Stegmann, Lena

AU - Cremer, Anjali

AU - Martin, Margarethe

AU - Lohmeyer, Julian

AU - Michaelis, Martin

AU - Hornung, Veit

AU - Schliemann, Christoph

AU - Berdel, Wolfgang E.

AU - Hartmann, Wolfgang

AU - Wardelmann, Eva

AU - Comoglio, Federico

AU - Hansmann, Martin-Leo

AU - Yakunin, Alexander F.

AU - Geisslinger, Gerd

AU - Stroebel, Philipp

AU - Ferreiros, Nerea

AU - Serve, Hubert

AU - Keppler, Oliver T.

AU - Cinatl, Jindrich, Jr.

PY - 2017/2

Y1 - 2017/2

UR - https://static-content.springer.com/esm/art%3A10.1038%2Fnm.4255/MediaObjects/41591_2017_BFnm4255_MOESM6_ESM.pdf

U2 - 10.1038/nm.4255

DO - 10.1038/nm.4255

M3 - Article

SN - 1078-8956

VL - 23

SP - 250

EP - 255

JO - Nature Medicine

JF - Nature Medicine

IS - 2

ER -

SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia

Access to Document

Other files and links

Cite this